Product Information

MIDODRINE HCL 5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1070 per EA under NDC 00378190201. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Sep 10, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MIDODRINE HCL 5 MG TABLET

midodrine hydrochloride
$0.1070per EA

Strength

5 mg/1

NDC

00378190201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MIDODRINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076577

FDA Approved

9/10/2003

TE Code

AB

On Market Since

9/11/2003

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for MIDODRINE HCL 5 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 73.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1070 per EA
All-time high$0.7270 (Apr 15, 2015)
All-time low$0.1070 (Oct 21, 2026)
52-week high$0.1138
52-week low$0.1070
Median price$0.3935
Average price$0.3532
Largest weekly change+49.4% (Feb 18, 2015)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-3.9%

3M

-4.5%

6M

-3.9%

1Y

-5.4%

3Y

-33.7%

5Y

-69.8%

All

-73.4%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MIDODRINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.1070 per EA (NDC 00378190201), effective Nov 11, 2026.

How has the price of MIDODRINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIDODRINE HCL 5 MG TABLET has declined 73.4%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for MIDODRINE HCL 5 MG TABLET has ranged from a low of $0.1070 (Oct 21, 2026) to a high of $0.7270 (Apr 15, 2015), with a median of $0.3935 per EA.

Are there cheaper alternatives to MIDODRINE HCL 5 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIDODRINE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MIDODRINE HCL 5 MG TABLET?

MIDODRINE HCL 5 MG TABLET (NDC 00378190201) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.